[Guidelines on the management of valvular heart disease].

Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease

New European guidelines on the management of valvular heart disease-supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)-were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve repl...

Pericardial disease.

In contrast to coronary artery disease, heart failure, valvular disease, and other topics in the field of cardiology, there are few data from randomized trials to guide physicians in the management of pericardial diseases. Although there are no American Heart Association/American College of Cardiology guidelines on this topic, the European Society of Cardiology has recently published useful gui...

What went wrong and how it got right: heart team provides value in transcatheter aortic valve replacement.

longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2009;2:356–64. 11. Kearney LG, Lu K, Ord M, Patel SK, Profitis K, Matalanis G et al. Global longitudinal strain is a strong independent predictor of all-cause mortality in patients with aortic stenosis. Eur Heart J Cardiovasc Imag 2012;13:827–833. 12. Lancellotti P, Donal E, Magne J, ...

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Transcathether Valve Replacement and Valve Repair

According to the American Heart Association/American College of Cardiology Guidelines for the Management of Patients with Valvular Heart Disease, echocardiography (transthoracic echocardiography [TTE] or transesophageal echocardiography [TEE]) is the imaging modality of choice for the assessment of valvular heart disease in patients. Numerous less invasive therapies such as percutaneous or tran...

Management of valvular disease in pregnancy: a global perspective.

Valvular heart disease (VHD) in pregnant women, whether due to congenital or acquired aetiologies, poses a challenge to clinicians and their patients. Significant valve disease, which can affect a single valve or several valves, increases the risk of pregnancy to the mother and foetus and requires a careful preconception risk assessment and, subsequently during pregnancy, specialized care to mi...